Axsome Therapeutics, Inc. SEC filings AXSM
Axsome Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Jun 19, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| EFFECT | Filing | Dec 16, 2016 | — |
| CORRESP | Letter to the SEC | Dec 15, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2016 | — |
| CT ORDER | Filing | Dec 22, 2015 | — |
| EFFECT | Filing | Nov 19, 2015 | — |
| CERTNAS | Auto-generated paper document | Nov 17, 2015 | — |
| 8-A12B | Filing | Nov 16, 2015 | — |
| CORRESP | Letter to the SEC | Nov 16, 2015 | — |
| CORRESP | Letter to the SEC | Nov 16, 2015 | — |
| CORRESP | Letter to the SEC | Oct 29, 2015 | — |
| CORRESP | Letter to the SEC | Oct 13, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2015 | — |
| DRS | Filing | Aug 25, 2015 | — |
| D | Filing | May 19, 2015 | — |
| D | Filing | Jan 7, 2015 | — |
| D | Filing | Sep 23, 2014 | — |
| D/A | Filing | Oct 30, 2013 | — |
| D | Filing | Jul 3, 2013 | — |
| D | Filing | Jun 19, 2013 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1579428
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.